Chronicle Journal: Finance

Mylan Schedules Fourth Quarter and Year End 2014 Financial Results Conference Call and Live Webcast

PITTSBURGH, Feb. 9, 2015 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) announced today that it will host a conference call and live webcast, including a slide presentation, on Monday, March 2, 2015, at 4:30 p.m. ET, to review the company's financial results for the fourth quarter and year ended Dec. 31, 2014. The company also will be providing its financial guidance for 2015.  Mylan will release its financial results on March 2 after the market closes.


The dial-in number to access the call is 800.514.4861 or 678.809.2405 for international callers. A replay, available for approximately seven days, will be available at 855.859.2056 or 404.537.3406 for international callers; passcode 80024983.

To access the live webcast, please log on to Mylan's Web site ( at least 15 minutes before the event is to begin to register and download or install any necessary software. A replay of the webcast will be available on for a limited time.

About Mylan

Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 1,300 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately 40% of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in approximately 140 countries and territories. Our workforce of more than 25,000 people is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around the world. Learn more at 

Logo -

To view the original version on PR Newswire, visit:

SOURCE Mylan Inc.

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.